Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 7.47
(-0.53%)
CNY 7.47
(-0.53%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 25.4 Million CNY | -43.23% |
| 2022 | 44.75 Million CNY | 25.51% |
| 2021 | 35.65 Million CNY | 119.88% |
| 2020 | -179.36 Million CNY | -2382.85% |
| 2019 | 7.85 Million CNY | 106.21% |
| 2018 | -126.47 Million CNY | -186.42% |
| 2017 | 146.35 Million CNY | -46.92% |
| 2016 | 275.71 Million CNY | 56.63% |
| 2015 | 176.03 Million CNY | 34.1% |
| 2014 | 131.26 Million CNY | 26.12% |
| 2013 | 104.08 Million CNY | 14.52% |
| 2012 | 90.88 Million CNY | 33.83% |
| 2011 | 67.91 Million CNY | 57.59% |
| 2010 | 43.09 Million CNY | 125.81% |
| 2009 | 19.08 Million CNY | 5.69% |
| 2008 | 18.05 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -29.01 Million CNY | -775.27% |
| 2024 Q3 | -6.03 Million CNY | 79.19% |
| 2024 Q1 | 4.29 Million CNY | 107.95% |
| 2023 Q4 | -54.03 Million CNY | -986.17% |
| 2023 Q1 | 22.52 Million CNY | 3219.01% |
| 2023 FY | 25.4 Million CNY | -43.23% |
| 2023 Q2 | 50.82 Million CNY | 125.62% |
| 2023 Q3 | 6.09 Million CNY | -88.0% |
| 2022 Q3 | 9.62 Million CNY | 20.63% |
| 2022 FY | 44.75 Million CNY | 25.51% |
| 2022 Q1 | 27.65 Million CNY | 5733.26% |
| 2022 Q2 | 7.98 Million CNY | -71.14% |
| 2022 Q4 | 678.67 Thousand CNY | -92.95% |
| 2021 Q2 | 16.46 Million CNY | 57.0% |
| 2021 Q4 | -490.86 Thousand CNY | -105.34% |
| 2021 FY | 35.65 Million CNY | 119.88% |
| 2021 Q1 | 10.48 Million CNY | 106.93% |
| 2021 Q3 | 9.19 Million CNY | -44.18% |
| 2020 Q1 | 416.96 Thousand CNY | 101.33% |
| 2020 FY | -179.36 Million CNY | -2382.85% |
| 2020 Q2 | -14.97 Million CNY | -3692.16% |
| 2020 Q4 | -151.31 Million CNY | -1021.22% |
| 2020 Q3 | -13.49 Million CNY | 9.9% |
| 2019 FY | 7.85 Million CNY | 106.21% |
| 2019 Q4 | -31.29 Million CNY | -332.56% |
| 2019 Q3 | 13.45 Million CNY | 115.06% |
| 2019 Q2 | 6.25 Million CNY | -67.81% |
| 2019 Q1 | 19.43 Million CNY | 109.51% |
| 2018 Q1 | 40.85 Million CNY | 530.69% |
| 2018 FY | -126.47 Million CNY | -186.42% |
| 2018 Q3 | 27.04 Million CNY | 169.62% |
| 2018 Q4 | -204.39 Million CNY | -855.86% |
| 2018 Q2 | 10.02 Million CNY | -75.45% |
| 2017 Q4 | 6.47 Million CNY | -88.57% |
| 2017 Q2 | 33.13 Million CNY | -33.82% |
| 2017 FY | 146.35 Million CNY | -46.92% |
| 2017 Q3 | 56.68 Million CNY | 71.08% |
| 2017 Q1 | 50.06 Million CNY | -26.82% |
| 2016 Q2 | 52.13 Million CNY | -0.14% |
| 2016 Q4 | 68.41 Million CNY | -33.56% |
| 2016 Q1 | 52.2 Million CNY | 7.66% |
| 2016 Q3 | 102.96 Million CNY | 97.52% |
| 2016 FY | 275.71 Million CNY | 56.63% |
| 2015 Q4 | 48.49 Million CNY | 14.43% |
| 2015 Q3 | 42.37 Million CNY | -1.69% |
| 2015 Q2 | 43.1 Million CNY | 2.48% |
| 2015 FY | 176.03 Million CNY | 34.1% |
| 2015 Q1 | 42.06 Million CNY | 34.31% |
| 2014 FY | 131.26 Million CNY | 26.12% |
| 2014 Q4 | 31.31 Million CNY | -12.92% |
| 2014 Q3 | 35.96 Million CNY | 16.21% |
| 2014 Q2 | 30.94 Million CNY | -6.33% |
| 2014 Q1 | 33.03 Million CNY | 5.68% |
| 2013 Q3 | 27.75 Million CNY | 24.86% |
| 2013 Q1 | 22.82 Million CNY | 0.0% |
| 2013 FY | 104.08 Million CNY | 14.52% |
| 2013 Q4 | 31.26 Million CNY | 12.63% |
| 2013 Q2 | 22.23 Million CNY | -2.63% |
| 2012 FY | 90.88 Million CNY | 33.83% |
| 2011 Q4 | 15.09 Million CNY | 0.0% |
| 2011 FY | 67.91 Million CNY | 57.59% |
| 2010 FY | 43.09 Million CNY | 125.81% |
| 2009 FY | 19.08 Million CNY | 5.69% |
| 2008 FY | 18.05 Million CNY | 0.0% |